Macrolide Antibiotics: Ribosomal Action, Clinical Uses, Resistance and QT Safety

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance.

Overview

Macrolides include erythromycin, clarithromycin and azithromycin. They inhibit bacterial protein synthesis and remain useful for certain atypical respiratory pathogens, pertussis and selected other infections; widespread resistance limits empiric use for some syndromes [1–3].

Classification and mechanisms

  • 14-membered lactone ring: erythromycin, clarithromycin.
  • 15-membered azalide: azithromycin.
  • 16-membered: examples include spiramycin and josamycin in countries where marketed.
  • Ketolide: telithromycin is a chemically modified 14-membered ketolide with important safety restrictions, not a 16-membered macrolide [1].

Macrolides bind 23S rRNA in the 50S ribosomal subunit, impeding the nascent peptide exit tunnel and protein synthesis. Activity is usually bacteriostatic, occasionally bactericidal under organism/exposure-specific conditions [1].

Antibacterial spectrum and treatment

Typical indications include selected community-acquired respiratory infections where guidelines and local resistance permit, macrolide-susceptible Mycoplasma pneumoniae pneumonia, pertussis, and some non-tuberculous mycobacterial disease as part of combinations. Mycoplasmas lack a cell wall and cannot be treated with beta-lactams [2]. A macrolide alone should not be assumed effective for pneumococcal pneumonia in regions with significant resistance. Macrolide-resistant Mycoplasma varies substantially by geography and patients not improving may require an alternative under clinical guidance [2].

Pharmacokinetics and interactions

Azithromycin has extensive tissue distribution and relatively prolonged terminal half-life. Clarithromycin and erythromycin inhibit CYP3A4 and can interact with simvastatin, certain antiarrhythmics, anticoagulants and numerous other drugs. Azithromycin has less CYP3A4 inhibition but is not interaction-free. Clarithromycin requires renal-dose review and its active metabolite contributes to activity; verify regimen and formulation [1].

Adverse effects and precautions

Nausea, abdominal discomfort and diarrhea are common. Macrolides may cause liver injury, QT prolongation and torsades de pointes, especially with baseline prolonged QT, electrolyte depletion, bradycardia or other QT-prolonging agents [3]. Azithromycin can exacerbate myasthenia gravis. Erythromycin may cause cholestatic hepatitis and, through motilin-receptor agonism, gastric motility effects. Avoid casual use for self-limited viral illnesses [1,3].

Resistance and stewardship

Target modification via erm-mediated 23S methylation and mef-associated efflux are prominent resistance mechanisms. Check local antibiograms, pathogen-directed recommendations and patient-specific cardiac/interaction risks before selecting therapy [1–3].

References

  1. Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
  2. Centers for Disease Control and Prevention. Clinical care of Mycoplasma pneumoniae infection. 2026 May 18. Available from: https://www.cdc.gov/mycoplasma/hcp/clinical-care/index.html
  3. US Food and Drug Administration. FDA drug safety communication: azithromycin and risk of potentially fatal heart rhythms. 2013 Mar 12. Available from: https://www.fda.gov/media/85787/download
Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *